APO Research
Talk to an analyst

APO RESEARCH · REPORT

Osimertinib

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Osimertinib Market Analysis and Forecast 2026-2032

23 December 2025195 pages

Choose your research edition.

Industry ResearchOsimertinib Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Osimertinib Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Osimertinib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Osimertinib Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Osimertinib Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Osimertinib market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Osimertinib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Osimertinib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Osimertinib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Osimertinib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Osimertinib include Beacon Pharma, Drug International, Everest Pharmaceuticals, Incepta Pharmaceuticals Limited and AstraZeneca, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Osimertinib, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Osimertinib, also provides the sales of main regions and countries. Of the upcoming market potential for Osimertinib, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Osimertinib sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Osimertinib market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Osimertinib sales, projected growth trends, production technology, application and end-user industry.

Osimertinib Segment by Company

Beacon Pharma

Drug International

Everest Pharmaceuticals

Incepta Pharmaceuticals Limited

AstraZeneca

Osimertinib Segment by Type

80mg*30 Tablets

80mg*10 Tablets

40mg*30 Tablets

40mg*10 Tablets

Osimertinib Segment by Application

Locally Advanced NSCLC

Metastatic NSCLC

Others

Osimertinib Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Osimertinib market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Osimertinib and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Osimertinib.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Osimertinib in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Osimertinib manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Osimertinib sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Osimertinib Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 80mg*30 Tablets Major Manufacturers Table 3. 80mg*10 Tablets Major Manufacturers Table 4. 40mg*30 Tablets Major Manufacturers Table 5. 40mg*10 Tablets Major Manufacturers Table 6. Global Osimertinib Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Locally Advanced NSCLC Major Manufacturers Table 8. Metastatic NSCLC Major Manufacturers Table 9. Others Major Manufacturers Table 10. Osimertinib Industry Trends Table 11. Osimertinib Industry Drivers Table 12. Osimertinib Industry Opportunities and Challenges Table 13. Osimertinib Industry Restraints Table 14. Global Osimertinib Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Osimertinib Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Osimertinib Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Osimertinib Revenue Market Share by Region (2021-2026) Table 18. Global Osimertinib Revenue Market Share by Region (2027-2032) Table 19. Global Osimertinib Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k pcs) Table 20. Global Osimertinib Sales by Region (2021-2026) & (k pcs) Table 21. Global Osimertinib Sales by Region (2027-2032) & (k pcs) Table 22. Global Osimertinib Sales Market Share by Region (2021-2026) Table 23. Global Osimertinib Sales Market Share by Region (2027-2032) Table 24. Global Osimertinib Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Osimertinib Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Osimertinib Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Osimertinib Sales Market Share by Manufacturers (2021-2026) Table 28. Global Osimertinib Sales Price (US$/pcs) of Manufacturers (2021-2026) Table 29. Global Osimertinib Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Osimertinib Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Osimertinib Manufacturers, Product Type & Application Table 32. Global Osimertinib Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Osimertinib by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Osimertinib Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Osimertinib Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Osimertinib Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Osimertinib Revenue Market Share by Type (2021-2026) Table 39. Global Osimertinib Revenue Market Share by Type (2027-2032) Table 40. Global Osimertinib Sales by Type 2021 VS 2025 VS 2032 (k pcs) Table 41. Global Osimertinib Sales by Type (2021-2026) & (k pcs) Table 42. Global Osimertinib Sales by Type (2027-2032) & (k pcs) Table 43. Global Osimertinib Sales Market Share by Type (2021-2026) Table 44. Global Osimertinib Sales Market Share by Type (2027-2032) Table 45. Global Osimertinib Price by Type (2021-2026) & (US$/pcs) Table 46. Global Osimertinib Price by Type (2027-2032) & (US$/pcs) Table 47. Global Osimertinib Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Osimertinib Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Osimertinib Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Osimertinib Revenue Market Share by Application (2021-2026) Table 51. Global Osimertinib Revenue Market Share by Application (2027-2032) Table 52. Global Osimertinib Sales by Application 2021 VS 2025 VS 2032 (k pcs) Table 53. Global Osimertinib Sales by Application (2021-2026) & (k pcs) Table 54. Global Osimertinib Sales by Application (2027-2032) & (k pcs) Table 55. Global Osimertinib Sales Market Share by Application (2021-2026) Table 56. Global Osimertinib Sales Market Share by Application (2027-2032) Table 57. Global Osimertinib Price by Application (2021-2026) & (US$/pcs) Table 58. Global Osimertinib Price by Application (2027-2032) & (US$/pcs) Table 59. Beacon Pharma Company Information Table 60. Beacon Pharma Business Overview Table 61. Beacon Pharma Osimertinib Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 62. Beacon Pharma Osimertinib Product Portfolio Table 63. Beacon Pharma Recent Development Table 64. Drug International Company Information Table 65. Drug International Business Overview Table 66. Drug International Osimertinib Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 67. Drug International Osimertinib Product Portfolio Table 68. Drug International Recent Development Table 69. Everest Pharmaceuticals Company Information Table 70. Everest Pharmaceuticals Business Overview Table 71. Everest Pharmaceuticals Osimertinib Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 72. Everest Pharmaceuticals Osimertinib Product Portfolio Table 73. Everest Pharmaceuticals Recent Development Table 74. Incepta Pharmaceuticals Limited Company Information Table 75. Incepta Pharmaceuticals Limited Business Overview Table 76. Incepta Pharmaceuticals Limited Osimertinib Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 77. Incepta Pharmaceuticals Limited Osimertinib Product Portfolio Table 78. Incepta Pharmaceuticals Limited Recent Development Table 79. AstraZeneca Company Information Table 80. AstraZeneca Business Overview Table 81. AstraZeneca Osimertinib Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 82. AstraZeneca Osimertinib Product Portfolio Table 83. AstraZeneca Recent Development Table 84. North America Osimertinib Revenue by Type (2021-2026) & (US$ Million) Table 85. North America Osimertinib Revenue by Type (2027-2032) & (US$ Million) Table 86. North America Osimertinib Sales by Type (2021-2026) & (k pcs) Table 87. North America Osimertinib Sales by Type (2027-2032) & (k pcs) Table 88. North America Osimertinib Sales Price by Type (2021-2026) & (US$/pcs) Table 89. North America Osimertinib Sales Price by Type (2027-2032) & (US$/pcs) Table 90. North America Osimertinib Revenue by Application (2021-2026) & (US$ Million) Table 91. North America Osimertinib Revenue by Application (2027-2032) & (US$ Million) Table 92. North America Osimertinib Sales by Application (2021-2026) & (k pcs) Table 93. North America Osimertinib Sales by Application (2027-2032) & (k pcs) Table 94. North America Osimertinib Sales Price by Application (2021-2026) & (US$/pcs) Table 95. North America Osimertinib Sales Price by Application (2027-2032) & (US$/pcs) Table 96. North America Osimertinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. North America Osimertinib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 98. North America Osimertinib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 99. North America Osimertinib Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 100. North America Osimertinib Sales by Country (2021-2026) & (k pcs) Table 101. North America Osimertinib Sales by Country (2027-2032) & (k pcs) Table 102. North America Osimertinib Sales Price by Country (2021-2026) & (US$/pcs) Table 103. North America Osimertinib Sales Price by Country (2027-2032) & (US$/pcs) Table 104. United States Osimertinib Revenue (2021-2032) & (US$ Million) Table 105. Canada Osimertinib Revenue (2021-2032) & (US$ Million) Table 106. Mexico Osimertinib Revenue (2021-2032) & (US$ Million) Table 107. Europe Osimertinib Revenue by Type (2021-2026) & (US$ Million) Table 108. Europe Osimertinib Revenue by Type (2027-2032) & (US$ Million) Table 109. Europe Osimertinib Sales by Type (2021-2026) & (k pcs) Table 110. Europe Osimertinib Sales by Type (2027-2032) & (k pcs) Table 111. Europe Osimertinib Sales Price by Type (2021-2026) & (US$/pcs) Table 112. Europe Osimertinib Sales Price by Type (2027-2032) & (US$/pcs) Table 113. Europe Osimertinib Revenue by Application (2021-2026) & (US$ Million) Table 114. Europe Osimertinib Revenue by Application (2027-2032) & (US$ Million) Table 115. Europe Osimertinib Sales by Application (2021-2026) & (k pcs) Table 116. Europe Osimertinib Sales by Application (2027-2032) & (k pcs) Table 117. Europe Osimertinib Sales Price by Application (2021-2026) & (US$/pcs) Table 118. Europe Osimertinib Sales Price by Application (2027-2032) & (US$/pcs) Table 119. Europe Osimertinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. Europe Osimertinib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 121. Europe Osimertinib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 122. Europe Osimertinib Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 123. Europe Osimertinib Sales by Country (2021-2026) & (k pcs) Table 124. Europe Osimertinib Sales by Country (2027-2032) & (k pcs) Table 125. Europe Osimertinib Sales Price by Country (2021-2026) & (US$/pcs) Table 126. Europe Osimertinib Sales Price by Country (2027-2032) & (US$/pcs) Table 127. Germany Osimertinib Revenue (2021-2032) & (US$ Million) Table 128. France Osimertinib Revenue (2021-2032) & (US$ Million) Table 129. U.K. Osimertinib Revenue (2021-2032) & (US$ Million) Table 130. Italy Osimertinib Revenue (2021-2032) & (US$ Million) Table 131. Russia Osimertinib Revenue (2021-2032) & (US$ Million) Table 132. Spain Osimertinib Revenue (2021-2032) & (US$ Million) Table 133. Netherlands Osimertinib Revenue (2021-2032) & (US$ Million) Table 134. Switzerland Osimertinib Revenue (2021-2032) & (US$ Million) Table 135. Sweden Osimertinib Revenue (2021-2032) & (US$ Million) Table 136. Poland Osimertinib Revenue (2021-2032) & (US$ Million) Table 137. China Osimertinib Revenue by Type (2021-2026) & (US$ Million) Table 138. China Osimertinib Revenue by Type (2027-2032) & (US$ Million) Table 139. China Osimertinib Sales by Type (2021-2026) & (k pcs) Table 140. China Osimertinib Sales by Type (2027-2032) & (k pcs) Table 141. China Osimertinib Sales Price by Type (2021-2026) & (US$/pcs) Table 142. China Osimertinib Sales Price by Type (2027-2032) & (US$/pcs) Table 143. China Osimertinib Revenue by Application (2021-2026) & (US$ Million) Table 144. China Osimertinib Revenue by Application (2027-2032) & (US$ Million) Table 145. China Osimertinib Sales by Application (2021-2026) & (k pcs) Table 146. China Osimertinib Sales by Application (2027-2032) & (k pcs) Table 147. China Osimertinib Sales Price by Application (2021-2026) & (US$/pcs) Table 148. China Osimertinib Sales Price by Application (2027-2032) & (US$/pcs) Table 149. Asia Osimertinib Revenue by Type (2021-2026) & (US$ Million) Table 150. Asia Osimertinib Revenue by Type (2027-2032) & (US$ Million) Table 151. Asia Osimertinib Sales by Type (2021-2026) & (k pcs) Table 152. Asia Osimertinib Sales by Type (2027-2032) & (k pcs) Table 153. Asia Osimertinib Sales Price by Type (2021-2026) & (US$/pcs) Table 154. Asia Osimertinib Sales Price by Type (2027-2032) & (US$/pcs) Table 155. Asia Osimertinib Revenue by Application (2021-2026) & (US$ Million) Table 156. Asia Osimertinib Revenue by Application (2027-2032) & (US$ Million) Table 157. Asia Osimertinib Sales by Application (2021-2026) & (k pcs) Table 158. Asia Osimertinib Sales by Application (2027-2032) & (k pcs) Table 159. Asia Osimertinib Sales Price by Application (2021-2026) & (US$/pcs) Table 160. Asia Osimertinib Sales Price by Application (2027-2032) & (US$/pcs) Table 161. Asia Osimertinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 162. Asia Osimertinib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 163. Asia Osimertinib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 164. Asia Osimertinib Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 165. Asia Osimertinib Sales by Country (2021-2026) & (k pcs) Table 166. Asia Osimertinib Sales by Country (2027-2032) & (k pcs) Table 167. Asia Osimertinib Sales Price by Country (2021-2026) & (US$/pcs) Table 168. Asia Osimertinib Sales Price by Country (2027-2032) & (US$/pcs) Table 169. Japan Osimertinib Revenue (2021-2032) & (US$ Million) Table 170. South Korea Osimertinib Revenue (2021-2032) & (US$ Million) Table 171. India Osimertinib Revenue (2021-2032) & (US$ Million) Table 172. Australia Osimertinib Revenue (2021-2032) & (US$ Million) Table 173. Taiwan Osimertinib Revenue (2021-2032) & (US$ Million) Table 174. Southeast Asia Osimertinib Revenue (2021-2032) & (US$ Million) Table 175. SAMEA Osimertinib Revenue by Type (2021-2026) & (US$ Million) Table 176. SAMEA Osimertinib Revenue by Type (2027-2032) & (US$ Million) Table 177. SAMEA Osimertinib Sales by Type (2021-2026) & (k pcs) Table 178. SAMEA Osimertinib Sales by Type (2027-2032) & (k pcs) Table 179. SAMEA Osimertinib Sales Price by Type (2021-2026) & (US$/pcs) Table 180. SAMEA Osimertinib Sales Price by Type (2027-2032) & (US$/pcs) Table 181. SAMEA Osimertinib Revenue by Application (2021-2026) & (US$ Million) Table 182. SAMEA Osimertinib Revenue by Application (2027-2032) & (US$ Million) Table 183. SAMEA Osimertinib Sales by Application (2021-2026) & (k pcs) Table 184. SAMEA Osimertinib Sales by Application (2027-2032) & (k pcs) Table 185. SAMEA Osimertinib Sales Price by Application (2021-2026) & (US$/pcs) Table 186. SAMEA Osimertinib Sales Price by Application (2027-2032) & (US$/pcs) Table 187. SAMEA Osimertinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 188. SAMEA Osimertinib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 189. SAMEA Osimertinib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 190. SAMEA Osimertinib Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 191. SAMEA Osimertinib Sales by Country (2021-2026) & (k pcs) Table 192. SAMEA Osimertinib Sales by Country (2027-2032) & (k pcs) Table 193. SAMEA Osimertinib Sales Price by Country (2021-2026) & (US$/pcs) Table 194. SAMEA Osimertinib Sales Price by Country (2027-2032) & (US$/pcs) Table 195. Brazil Osimertinib Revenue (2021-2032) & (US$ Million) Table 196. Argentina Osimertinib Revenue (2021-2032) & (US$ Million) Table 197. Chile Osimertinib Revenue (2021-2032) & (US$ Million) Table 198. Colombia Osimertinib Revenue (2021-2032) & (US$ Million) Table 199. Peru Osimertinib Revenue (2021-2032) & (US$ Million) Table 200. Saudi Arabia Osimertinib Revenue (2021-2032) & (US$ Million) Table 201. Israel Osimertinib Revenue (2021-2032) & (US$ Million) Table 202. UAE Osimertinib Revenue (2021-2032) & (US$ Million) Table 203. Turkey Osimertinib Revenue (2021-2032) & (US$ Million) Table 204. Iran Osimertinib Revenue (2021-2032) & (US$ Million) Table 205. Egypt Osimertinib Revenue (2021-2032) & (US$ Million) Table 206. Key Raw Materials Table 207. Raw Materials Key Suppliers Table 208. Osimertinib Distributors List Table 209. Osimertinib Customers List Table 210. Research Programs/Design for This Report Table 211. Authors List of This Report Table 212. Secondary Sources Table 213. Primary Sources List of Figures Figure 1. Osimertinib Image Figure 2. Global Osimertinib Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Osimertinib Market Size Share 2021 VS 2025 VS 2032 Figure 4. 80mg*30 Tablets Image Figure 5. 80mg*10 Tablets Image Figure 6. 40mg*30 Tablets Image Figure 7. 40mg*10 Tablets Image Figure 8. Global Osimertinib Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Osimertinib Market Size Share 2021 VS 2025 VS 2032 Figure 10. Locally Advanced NSCLC Image Figure 11. Metastatic NSCLC Image Figure 12. Others Image Figure 13. Global Osimertinib Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Osimertinib Revenue (2021-2032) & (US$ Million) Figure 15. Global Osimertinib Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Osimertinib Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Osimertinib Revenue Market Share by Region (2021-2032) Figure 18. Global Osimertinib Sales (2021-2032) & (k pcs) Figure 19. Global Osimertinib Sales by Region: 2021 VS 2025 VS 2032 (k pcs) Figure 20. Global Osimertinib Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Osimertinib Sales YoY (2021-2032) & (k pcs) Figure 22. Europe Osimertinib Sales YoY (2021-2032) & (k pcs) Figure 23. China Osimertinib Sales YoY (2021-2032) & (k pcs) Figure 24. Asia (Excluding China) Osimertinib Sales YoY (2021-2032) & (k pcs) Figure 25. South America, Middle East and Africa Osimertinib Sales YoY (2021-2032) & (k pcs) Figure 26. Global Osimertinib Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Osimertinib Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Osimertinib Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Osimertinib Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Osimertinib Revenue Market Share by Type (2021-2032) Figure 32. Global Osimertinib Sales by Type (2021 VS 2025 VS 2032) & (k pcs) Figure 33. Global Osimertinib Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Osimertinib Sales Market Share by Type (2021-2032) Figure 35. Global Osimertinib Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Osimertinib Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Osimertinib Revenue Market Share by Application (2021-2032) Figure 38. Global Osimertinib Sales by Application (2021 VS 2025 VS 2032) & (k pcs) Figure 39. Global Osimertinib Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Osimertinib Sales Market Share by Application (2021-2032) Figure 41. North America Osimertinib Revenue Share by Type (2021-2032) Figure 42. North America Osimertinib Sales Share by Type (2021-2032) Figure 43. North America Osimertinib Revenue Share by Application (2021-2032) Figure 44. North America Osimertinib Sales Share by Application (2021-2032) Figure 45. North America Osimertinib Revenue Share by Country (2021-2032) Figure 46. North America Osimertinib Sales Share by Country (2021-2032) Figure 47. Europe Osimertinib Revenue Share by Type (2021-2032) Figure 48. Europe Osimertinib Sales Share by Type (2021-2032) Figure 49. Europe Osimertinib Revenue Share by Application (2021-2032) Figure 50. Europe Osimertinib Sales Share by Application (2021-2032) Figure 51. Europe Osimertinib Revenue Share by Country (2021-2032) Figure 52. Europe Osimertinib Sales Share by Country (2021-2032) Figure 53. China Osimertinib Revenue Share by Type (2021-2032) Figure 54. China Osimertinib Sales Share by Type (2021-2032) Figure 55. China Osimertinib Revenue Share by Application (2021-2032) Figure 56. China Osimertinib Sales Share by Application (2021-2032) Figure 57. Asia Osimertinib Revenue Share by Type (2021-2032) Figure 58. Asia Osimertinib Sales Share by Type (2021-2032) Figure 59. Asia Osimertinib Revenue Share by Application (2021-2032) Figure 60. Asia Osimertinib Sales Share by Application (2021-2032) Figure 61. Asia Osimertinib Revenue Share by Country (2021-2032) Figure 62. Asia Osimertinib Sales Share by Country (2021-2032) Figure 63. SAMEA Osimertinib Revenue Share by Type (2021-2032) Figure 64. SAMEA Osimertinib Sales Share by Type (2021-2032) Figure 65. SAMEA Osimertinib Revenue Share by Application (2021-2032) Figure 66. SAMEA Osimertinib Sales Share by Application (2021-2032) Figure 67. SAMEA Osimertinib Revenue Share by Country (2021-2032) Figure 68. SAMEA Osimertinib Sales Share by Country (2021-2032) Figure 69. Osimertinib Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Osimertinib Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • 80mg*30 Tablets
  • 80mg*10 Tablets
  • 40mg*30 Tablets
  • 40mg*10 Tablets
Applications
  • Locally Advanced NSCLC
  • Metastatic NSCLC
  • Others
Companies covered
  • Beacon Pharma
  • Drug International
  • Everest Pharmaceuticals
  • Incepta Pharmaceuticals Limited
  • AstraZeneca

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Osimertinib Market by Type
  3. 1.2.1 Global Osimertinib Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 80mg*30 Tablets
  5. 1.2.3 80mg*10 Tablets
  6. 1.2.4 40mg*30 Tablets
  7. 1.2.5 40mg*10 Tablets
  8. 1.3 Osimertinib Market by Application
  9. 1.3.1 Global Osimertinib Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Locally Advanced NSCLC
  11. 1.3.3 Metastatic NSCLC
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Osimertinib Market Dynamics
  1. 2.1 Osimertinib Industry Trends
  2. 2.2 Osimertinib Industry Drivers
  3. 2.3 Osimertinib Industry Opportunities and Challenges
  4. 2.4 Osimertinib Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Osimertinib Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Osimertinib Revenue by Region
  3. 3.2.1 Global Osimertinib Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Osimertinib Revenue by Region (2021-2026)
  5. 3.2.3 Global Osimertinib Revenue by Region (2027-2032)
  6. 3.2.4 Global Osimertinib Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Osimertinib Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Osimertinib Sales by Region
  9. 3.4.1 Global Osimertinib Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Osimertinib Sales by Region (2021-2026)
  11. 3.4.3 Global Osimertinib Sales by Region (2027-2032)
  12. 3.4.4 Global Osimertinib Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Osimertinib Revenue by Manufacturers
  2. 4.1.1 Global Osimertinib Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Osimertinib Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Osimertinib Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Osimertinib Sales by Manufacturers
  6. 4.2.1 Global Osimertinib Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Osimertinib Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Osimertinib Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Osimertinib Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Osimertinib Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Osimertinib Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Osimertinib Manufacturers, Product Type & Application
  13. 4.7 Global Osimertinib Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Osimertinib Market CR5 and HHI
  16. 4.8.2 2025 Osimertinib Tier 1, Tier 2, and Tier 3
5 Osimertinib Market by Type
  1. 5.1 Global Osimertinib Revenue by Type
  2. 5.1.1 Global Osimertinib Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Osimertinib Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Osimertinib Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Osimertinib Sales by Type
  6. 5.2.1 Global Osimertinib Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Osimertinib Sales by Type (2021-2032) & (k pcs)
  8. 5.2.3 Global Osimertinib Sales Market Share by Type (2021-2032)
  9. 5.3 Global Osimertinib Price by Type
6 Osimertinib Market by Application
  1. 6.1 Global Osimertinib Revenue by Application
  2. 6.1.1 Global Osimertinib Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Osimertinib Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Osimertinib Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Osimertinib Sales by Application
  6. 6.2.1 Global Osimertinib Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Osimertinib Sales by Application (2021-2032) & (k pcs)
  8. 6.2.3 Global Osimertinib Sales Market Share by Application (2021-2032)
  9. 6.3 Global Osimertinib Price by Application
7 Company Profiles
  1. 7.1 Beacon Pharma
  2. 7.1.1 Beacon Pharma Company Information
  3. 7.1.2 Beacon Pharma Business Overview
  4. 7.1.3 Beacon Pharma Osimertinib Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Beacon Pharma Osimertinib Product Portfolio
  6. 7.1.5 Beacon Pharma Recent Developments
  7. 7.2 Drug International
  8. 7.2.1 Drug International Company Information
  9. 7.2.2 Drug International Business Overview
  10. 7.2.3 Drug International Osimertinib Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Drug International Osimertinib Product Portfolio
  12. 7.2.5 Drug International Recent Developments
  13. 7.3 Everest Pharmaceuticals
  14. 7.3.1 Everest Pharmaceuticals Company Information
  15. 7.3.2 Everest Pharmaceuticals Business Overview
  16. 7.3.3 Everest Pharmaceuticals Osimertinib Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Everest Pharmaceuticals Osimertinib Product Portfolio
  18. 7.3.5 Everest Pharmaceuticals Recent Developments
  19. 7.4 Incepta Pharmaceuticals Limited
  20. 7.4.1 Incepta Pharmaceuticals Limited Company Information
  21. 7.4.2 Incepta Pharmaceuticals Limited Business Overview
  22. 7.4.3 Incepta Pharmaceuticals Limited Osimertinib Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Incepta Pharmaceuticals Limited Osimertinib Product Portfolio
  24. 7.4.5 Incepta Pharmaceuticals Limited Recent Developments
  25. 7.5 AstraZeneca
  26. 7.5.1 AstraZeneca Company Information
  27. 7.5.2 AstraZeneca Business Overview
  28. 7.5.3 AstraZeneca Osimertinib Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 AstraZeneca Osimertinib Product Portfolio
  30. 7.5.5 AstraZeneca Recent Developments
8 North America
  1. 8.1 North America Osimertinib Market Size by Type
  2. 8.1.1 North America Osimertinib Revenue by Type (2021-2032)
  3. 8.1.2 North America Osimertinib Sales by Type (2021-2032)
  4. 8.1.3 North America Osimertinib Price by Type (2021-2032)
  5. 8.2 North America Osimertinib Market Size by Application
  6. 8.2.1 North America Osimertinib Revenue by Application (2021-2032)
  7. 8.2.2 North America Osimertinib Sales by Application (2021-2032)
  8. 8.2.3 North America Osimertinib Price by Application (2021-2032)
  9. 8.3 North America Osimertinib Market Size by Country
  10. 8.3.1 North America Osimertinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Osimertinib Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Osimertinib Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Osimertinib Market Size by Type
  2. 9.1.1 Europe Osimertinib Revenue by Type (2021-2032)
  3. 9.1.2 Europe Osimertinib Sales by Type (2021-2032)
  4. 9.1.3 Europe Osimertinib Price by Type (2021-2032)
  5. 9.2 Europe Osimertinib Market Size by Application
  6. 9.2.1 Europe Osimertinib Revenue by Application (2021-2032)
  7. 9.2.2 Europe Osimertinib Sales by Application (2021-2032)
  8. 9.2.3 Europe Osimertinib Price by Application (2021-2032)
  9. 9.3 Europe Osimertinib Market Size by Country
  10. 9.3.1 Europe Osimertinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Osimertinib Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Osimertinib Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Osimertinib Market Size by Type
  2. 10.1.1 China Osimertinib Revenue by Type (2021-2032)
  3. 10.1.2 China Osimertinib Sales by Type (2021-2032)
  4. 10.1.3 China Osimertinib Price by Type (2021-2032)
  5. 10.2 China Osimertinib Market Size by Application
  6. 10.2.1 China Osimertinib Revenue by Application (2021-2032)
  7. 10.2.2 China Osimertinib Sales by Application (2021-2032)
  8. 10.2.3 China Osimertinib Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Osimertinib Market Size by Type
  2. 11.1.1 Asia Osimertinib Revenue by Type (2021-2032)
  3. 11.1.2 Asia Osimertinib Sales by Type (2021-2032)
  4. 11.1.3 Asia Osimertinib Price by Type (2021-2032)
  5. 11.2 Asia Osimertinib Market Size by Application
  6. 11.2.1 Asia Osimertinib Revenue by Application (2021-2032)
  7. 11.2.2 Asia Osimertinib Sales by Application (2021-2032)
  8. 11.2.3 Asia Osimertinib Price by Application (2021-2032)
  9. 11.3 Asia Osimertinib Market Size by Country
  10. 11.3.1 Asia Osimertinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Osimertinib Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Osimertinib Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Osimertinib Market Size by Type
  2. 12.1.1 SAMEA Osimertinib Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Osimertinib Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Osimertinib Price by Type (2021-2032)
  5. 12.2 SAMEA Osimertinib Market Size by Application
  6. 12.2.1 SAMEA Osimertinib Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Osimertinib Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Osimertinib Price by Application (2021-2032)
  9. 12.3 SAMEA Osimertinib Market Size by Country
  10. 12.3.1 SAMEA Osimertinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Osimertinib Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Osimertinib Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Osimertinib Value Chain Analysis
  2. 13.1.1 Osimertinib Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Osimertinib Production Mode & Process
  6. 13.2 Osimertinib Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Osimertinib Distributors
  9. 13.2.3 Osimertinib Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst